Keanan Beierle , PA
Physician Assistant • Katy, TX
21308 Provincial Blvd
Katy, TX 774507580
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Keanan Beierle is listed in NPPES under Physician Assistant.
-
NPI assigned on December 28, 2010; this date does not establish years in practice.
-
Published CMS data list 727 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Duloxetine Hcl — 112 prescription fills, including refills.
- Clonazepam — 73 prescription fills, including refills.
- Trazodone Hcl — 66 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 24 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 65% of clinicians listed under Physician Assistant in Katy, TX (2024, 24 clinicians with data). Median for this group: 536. Middle half: 184 to 1,164.
More Part D prescriptions than 70% of clinicians listed under Physician Assistant in Texas (2024, 4,882 clinicians with data). Median for this group: 261. Middle half: 73 to 938.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 1,467 in 2020 to 727 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
21308 Provincial Blvd
Katy, TX 774507580
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Physician Assistant: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
1,065 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$56,299 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,654.64 across 82 records.
By nature of payment
- Food and Beverage: $1,654.64 across 82 records.
Reporting-company totals (3 largest of 19)
- ABBVIE INC.: $275.53 across 17 records.
- Otsuka America Pharmaceutical, Inc.: $167.73 across 8 records.
- Vanda Pharmaceuticals Inc.: $149.17 across 8 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2010
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Katy and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under Physician Assistant in Katy, TX (2024, 24 clinicians with data). Median for this group: 536. Middle half: 184 to 1,164.
More Part D prescriptions than 70% of clinicians listed under Physician Assistant in Texas (2024, 4,882 clinicians with data). Median for this group: 261. Middle half: 73 to 938.
Part D drug cost
A higher Part D drug cost than 60% of clinicians listed under Physician Assistant in Katy, TX (2024, 24 clinicians with data). Median for this group: $33,518. Middle half: $2,449 to $112,213.
A higher Part D drug cost than 65% of clinicians listed under Physician Assistant in Texas (2024, 4,882 clinicians with data). Median for this group: $7,999. Middle half: $749 to $103,240.
54 active clinicians are listed under Physician Assistant with a practice address in Katy, TX (11,008 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Katy
9.3% of these 54 clinicians have the CMS telehealth indicator.
59.3% of these 54 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 50% from 1,467 in 2020 to 727 in 2024.
- 2020: 1,467
- 2021: 545
- 2022: 698
- 2023: 610
- 2024: 727
-
30-day fills
30-day fills decreased 52% from 2,212 in 2020 to 1,065 in 2024.
- 2020: 2,212
- 2021: 743
- 2022: 989
- 2023: 852
- 2024: 1,065
-
Part D drug cost
Part D drug cost decreased 14% from $65,389 in 2020 to $56,299 in 2024.
- 2020: $65,389
- 2021: $14,358
- 2022: $12,688
- 2023: $34,090
- 2024: $56,299
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 64% from $1,011.42 in 2021 to $1,654.64 in 2025.
- 2021: $1,011.42
- 2022: $1,035.14
- 2023: $1,322.94
- 2024: $1,225.24
- 2025: $1,654.64
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 82 records totaling $1,654.64.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $34.05 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $33.64 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $33.25 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $31.60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $29.84 |
| Alkermes, Inc. |
Food and Beverage
In-kind items and services
|
ARISTADA | General | $28.60 |
| Tris Pharma Inc |
Food and Beverage
In-kind items and services
|
Dyanavel XR | General | $28.20 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $27.71 |
| Corium, LLC |
Food and Beverage
In-kind items and services
|
Azstarys | General | $26.62 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
COBENFY | General | $26.30 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $25.72 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $25.52 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $25.40 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $25.25 |
| Almatica Pharma LLC |
Food and Beverage
In-kind items and services
|
LOREEV XR | General | $25.12 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $25.12 |
| Collegium Pharmaceutical, Inc. |
Food and Beverage
Cash or cash equivalent
|
Jornay PM | General | $25.11 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $24.88 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
COBENFY | General | $24.53 |
| Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
APLENZIN | General | $24.14 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $24.11 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
COBENFY | General | $24.00 |
| Vertical Pharmaceuticals, LLC |
Food and Beverage
In-kind items and services
|
Relexxii | General | $23.21 |
| Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
APLENZIN | General | $23.14 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $22.83 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Duloxetine Hcl | Duloxetine Hcl | 112 | 4,509 | $1,485.89 | 14 |
| Clonazepam | Clonazepam | 73 | 2,036 | $951.56 | 13 |
| Trazodone Hcl | Trazodone Hcl | 66 | 4,287 | $1,036.99 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 52 | 1,945 | $1,117.44 | — |
| Escitalopram Oxalate | Escitalopram Oxalate | 48 | 2,135 | $543.38 | 13 |
| Alprazolam | Alprazolam | 42 | 1,260 | $89.14 | — |
| Lorazepam | Lorazepam | 36 | 1,052 | $233.90 | — |
| Buspirone Hcl | Buspirone Hcl | 29 | 1,830 | $462.12 | — |
| Gabapentin | Gabapentin | 24 | 1,740 | $530.19 | — |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | 780 | $248.28 | — |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 23 | 660 | $288.56 | — |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | 1,320 | $682.09 | — |
| Citalopram Hbr | Citalopram Hydrobromide | 21 | 870 | $60.43 | — |
| Bupropion Xl | Bupropion Hcl | 21 | 1,533 | $509.67 | — |
| Lamotrigine | Lamotrigine | 18 | 884 | $340.79 | — |
| Vilazodone Hcl | Vilazodone Hcl | 16 | 441 | $680.15 | — |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | 432 | $117.22 | — |
| Fluoxetine Hcl | Fluoxetine Hcl | 14 | 497 | $100.94 | — |
| Divalproex Sodium Er | Divalproex Sodium | 13 | 1,018 | $497.20 | — |
| Diazepam | Diazepam | 12 | 261 | $9.72 | — |
| Doxepin Hcl | Doxepin Hcl | 12 | 360 | $179.73 | — |
| Aripiprazole | Aripiprazole | 12 | 464 | $295.50 | — |
| Abilify Maintena | Aripiprazole | 11 | 308 | $29,965.84 | — |
| Rexulti | Brexpiprazole | 11 | 330 | $15,872.60 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 363A00000X
A physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant - Medical
Internal Medicine - Endocrinology, Diabetes & Metabolism
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
NURSEPRACTITIONER
Internal Medicine - Endocrinology, Diabetes & Metabolism
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
NPI status registered as active in NPPES database
Registered at 21308 PROVINCIAL BLVD, KATY, TX 774507580 (Tel: (832) 321-5180)
Registered at 21308 PROVINCIAL BLVD, KATY, TX 774507580 (Tel: (832) 321-5180)
Recorded as KEANAN BEIERLE, PA
Physician Assistant (license number reported to NPPES: TX PA0711117)
NPI status registered as active in NPPES database
Registered at 10111 RICHMOND AVE, SUITE 400, HOUSTON, TX 770424215 (Tel: 7135411177)
Registered at 20415 HIDDEN POINT LN, RICHMOND, TX 774077863 (Tel: 2817820061)
Recorded as KEANAN BEIERLE, PA
Physician Assistant
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Physician Assistants in Katy
All Physician Assistants in KatyMailing Address
21308 Provincial Blvd
Katy, TX 774507580
Phone: 8323215180